Skip to main content
Livermore
Livermore
ZHEN

Beutel, Goodman & Co Ltd.

SEC CIK
0001361974
Latest filing
Aug 12, 2026

GSK holding history

GSK plc in every 13F filed by Beutel, Goodman & Co Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GSK overviewAll 13F holders of GSKFull Q2 2026 holdings

Shares (Q2 2026)
11,584
Value
$607.0K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of GSK by Beutel, Goodman & Co Ltd., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202611,584$607.0K<0.1%+954+9.0%AddedHolders
Q1 202610,630$586.0K<0.1%−3,690−25.8%ReducedHolders
Q4 202514,320$702.0K<0.1%−3,370−19.1%ReducedHolders
Q3 202517,690$763.0K<0.1%+240+1.4%AddedHolders
Q2 202517,450$670.0K<0.1%+4,670+36.5%AddedHolders
Q1 202512,780$495.0K<0.1%+80+0.6%AddedHolders
Q4 202412,700$429.0K<0.1%−590−4.4%ReducedHolders
Q3 202413,290$543.0K<0.1%+130+1.0%AddedHolders
Q2 202413,160$506.0K<0.1%00.0%UnchangedHolders
Q1 202413,160$564.0K<0.1%+110+0.8%AddedHolders
Q4 202313,050$483.0K<0.1%+4,620+54.8%AddedHolders
Q3 20238,430$305.0K<0.1%+20+0.2%AddedHolders
Q2 20238,410$299.0K<0.1%+1,260+17.6%AddedHolders
Q1 20237,150$254.0K<0.1%+920+14.8%AddedHolders
Q4 20226,230$218.0K<0.1%−3,100−33.2%ReducedHolders
Q3 20229,330$274.0K<0.1%−3,445−27.0%ReducedHolders
Q2 202212,775$556.0K<0.1%−430−3.3%ReducedHolders
Q1 202213,205$575.0K<0.1%+970+7.9%AddedHolders
Q4 202112,235$539.0K<0.1%+1,005+8.9%AddedHolders
Q3 202111,230$429.0K<0.1%00.0%UnchangedHolders
Q2 202111,230$447.0K<0.1%+1,100+10.9%AddedHolders
Q1 202110,130$361.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.